Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

Journal of Viral Hepatitis

Volumn 22, Issue , 2015, Pages 4-20

  Liakina, V ^a,b   Hamid, S ^c   Tanaka, J ^d   Olafsson, S ^e   Sharara, A I ^f   Alavian, S M ^g,h   Gheorghe, L ⁱ   El Hassan, E S ^j   Abaalkhail, F ^k   Abbas, Z ^l   Abdou, A ^j   Abourached, A ^m   Al Braiki, F ⁿ   Al Hosani, F ^o   Al Jaberi, K ^o   Al Khatry, M ^p   Al Mulla, M A ^o   Al Quraishi, H ^j   Al Rifai, A ^q   Al Serkal, Y ^r   Alam, A ^s   Alashgar, H I ^t   Alawadhi, S ^j   Al Dabal, L ^j   Aldins, P ^u   Alfaleh, F Z ^v   Alghamdi, A S ^w   Al Hakeem, R ^x   Aljumah, A A ^y   Almessabi, A ⁿ   Alqutub, A N ^w   Alswat, K A ^z   Altraif, I ^y   Alzaabi, M ^aa   Andrea, N ^ab   Assiri, A M ^x   Babatin, M A ^w   Baqir, A ^ac   Barakat, M T ^o   Bergmann, O M ^e   Bizri, A R ^f   Blach, S ^ad   Chaudhry, A ^ae   Choi, M S ^af   Diab, T ^ag   Djauzi, S ^ah   El Khoury, S ^ai   Estes, C ^ad   Fakhry, S ^aj   Farooqi, J I ^e,ak,al   Fridjonsdottir, H ^e   Gani, R A ^ah   Ghafoor Khan, A ^al   Goldis, A ^am   Gottfredsson, M ^e   Gregorcic, S ^an   Hajarizadeh, B ^ao   Han, K H ^ap,aq   Hasan, I ^ah   Hashim, A ^t   Horvath, G ^ar   Hunyady, B ^as,at   Husni, R ^au   Jafri, W ^c   Jeruma, A ^av,aw,ax   Jonasson, J G ^e,al   Karlsdottir, B ^e   Kim, D Y ^aq   Kim, Y S ^ay   Koutoubi, Z ^az,ba   Lesmana, L A ^ah,ai,bb   Lim, Y S ^e,bb   Love A ^e,an,bc   Maimets, M ^bc   Makara, M ^bd   Malekzadeh, R ^be   Maticic M ^an   Memon, M S ^bf   Merat, S ^be   Mokhbat, J E ^au   Mourad, F H ^f   Muljono, D H ^bg,bh,bi   Nawaz, A ^bi   Nugrahini, N ^bj   Priohutomo, S ^bj   Qureshi, H ^bk   Rassam, P ^ai   Razavi, H ^ad   Razavi Shearer, D ^ad   Razavi Shearer, K ^ad   Rozentale, B ^av,aw,ax   Sadik, M ^bf   Saeed, K ^bl   Salamat, A ^bm   Salupere, R ^bc   Sanai, F M ^v   Sanityoso Sulaiman, A ^ah   Sayegh, R A ^bn   Schmelzer, J D ^ad   Sibley, A ^ad   Siddiq, M ^bo,bp,bq   Siddiqui, A M ^bq   Sigmundsdottir, G ^br,bs   Sigurdardottir, B ^e   Speiciene, D ^a   Sulaiman, A ^ah,ai,bt   Sultan, M A ^bt   Taha, M ^bu   Tarifi, H ^bu   Tayyab, G ^bv,bw,bx   Tolmane, I ^av   Ud Din, M ^bx   Umar, M ^by,bz,ca   Valantinas, J ^a   Videcnik Zorman J ^an,ao   Yaghi, C ^bn,bo   Yunihastuti, E ^ca   Yusuf, M A ^cb   Zuberi, B F ^cc   Gunter, J ^ad,ae   more..

^a VILNIUS UNIVERSITY   (Lithuania)

^b VILNIUS GEDIMINAS TECHNICAL UNIVERSITY   (Lithuania)

^c AGA KHAN UNIVERSITY   (Pakistan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^f AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h Middle East Liver Disease Center   (Iran)

ⁱ FUNDENI CLINICAL INSTITUTE   (Romania)

^j DUBAI HEALTH AUTHORITY   (United Arab Emirates)

^k ALFAISAL UNIVERSITY   (Saudi Arabia)

^l ZIAUDDIN UNIVERSITY   (Pakistan)

^m MINISTRY OF PUBLIC HEALTH   (Lebanon)

ⁿ Abu Dhabi Health Services Co   (United Arab Emirates)

^o Health Authority Abu Dhabi   (United Arab Emirates)

^p University of Ras Al Khaimah   (United Arab Emirates)

^q MAFRAQ HOSPITAL   (United Arab Emirates)

^r Ministry of Health United Arab Emirates   (United Arab Emirates)

^s SHAIKH ZAYED HOSPITAL   (Pakistan)

^t KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^u RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^v KING SAUD UNIVERSITY   (Saudi Arabia)

^w KING FAHAD MEDICAL CITY   (Saudi Arabia)

^x MINISTRY OF HEALTH   (Saudi Arabia)

^y KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^z KING SAUD UNIVERSITY   (Saudi Arabia)

^aa ZAYED MILITARY HOSPITAL   (United Arab Emirates)

^ab Daman National Health Insurance Company   (United Arab Emirates)

^ac Seyal Medical Centre   (Pakistan)

^ad Center for Disease Analysis   (United States)

^ae Gujranwala Liver Foundation Siddiq Sadiq Hospital   (Pakistan)

^af Sungkyunkwan University School of Medicine   (South Korea)

^ag AL AIN HOSPITAL   (United Arab Emirates)

^ah CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^ai UNIVERSITY OF BALAMAND   (Lebanon)

^aj ABU DHABI POLICE   (United Arab Emirates)

^ak KHYBER MEDICAL UNIVERSITY   (Pakistan)

^al LADY READING HOSPITAL   (Pakistan)

^am VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^an UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^ao UNIVERSITY OF NEW SOUTH WALES   (Australia)

^ap LA TROBE UNIVERSITY   (Australia)

^aq Yonsei University College of Medicine   (South Korea)

^ar Hepatology Center of Buda   (Hungary)

^as Kaposi Mor Teaching Hospital   (Hungary)

^at UNIVERSITY OF PÉCS   (Hungary)

^au RIZK HOSPITAL   (Lebanon)

^av Infectology Center of Latvia   (Latvia)

^aw RIGA STRADINS UNIVERSITY   (Latvia)

^ax ICELANDIC CANCER REGISTRY   (Iceland)

^ay Soonchunhyang University   (South Korea)

^az HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

^ba Medistra Hospital   (Indonesia)

^bb University of Ulsan College of Medicine   (South Korea)

^bc TARTU UNIVERSITY HOSPITAL   (Estonia)

^bd Szent Laszlo Hospital   (Hungary)

^be TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^bf Asian Institute of Medical Science   (Pakistan)

^bg EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^bh UNIVERSITY OF SYDNEY   (Australia)

^bi FATIMA MEMORIAL HOSPITAL   (Pakistan)

^bj MINISTRY OF HEALTH   (Indonesia)

^bk Pakistan Medical Research Council   (Pakistan)

^bl Khawar Clinic   (Pakistan)

^bm Military Hospital   (Pakistan)

^bn SAINT JOSEPH UNIVERSITY   (Lebanon)

^bo JINNAH HOSPITAL   (Pakistan)

^bp Yusra Medical College   (Pakistan)

^bq ALLAMA IQBAL MEDICAL COLLEGE   (Pakistan)

^br Centre for Health Security and Communicable Disease Control   (Iceland)

^bs Klinik Hati Prof Ali Sulaiman   (Indonesia)

^bt Health Funding Department Enaya Insurance Company   (United Arab Emirates)

^bu TAWAM HOSPITAL   (United Arab Emirates)

^bv Ameeruddin Medical College PGMI Lahore General Hospital M Phil Stud   (Pakistan)

^bw National Hospital and Medical Center   (Pakistan)

^bx Pakistan Society of Gastroenterology   (Pakistan)

^by RAWALPINDI MEDICAL COLLEGE   (Pakistan)

^bz HOLY FAMILY HOSPITAL   (Pakistan)

^ca UNIVERSITY OF INDONESIA   (Indonesia)

^cb SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

^cc DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

more..

Author keywords

diagnosis; disease burden; epidemiology; hepatitis C; hepatitis C virus; historical; incidence; mortality; prevalence; treatment

Indexed keywords

BOCEPREVIR; PEGINTERFERON; RIBAVIRIN; TELAPREVIR; ANTIVIRUS AGENT;

AGE DISTRIBUTION; ANTIVIRAL THERAPY; ARTICLE; BLOOD DONOR; DRUG USE; ESTONIA; GENDER; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUNGARY; ICELAND; INDONESIA; INJECTION DRUG USE; IRAN; LATVIA; LEBANON; LITHUANIA; LIVER TRANSPLANTATION; PAKISTAN; PREVALENCE; PRIORITY JOURNAL; ROMANIA; SAUDI ARABIA; SLOVENIA; SOUTH KOREA; SYSTEMATIC REVIEW; UNITED ARAB EMIRATES; VIREMIA; ADOLESCENT; ADULT; AGED; CHILD; CLASSIFICATION; FEMALE; GENOTYPE; HEALTH; HEPACIVIRUS; HEPATITIS C, CHRONIC; INFANT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; GLOBAL HEALTH; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INFANT; INFANT, NEWBORN; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84945351461     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12475     Document Type: Article

References (73)

1. Lozano R, Naghavi M, Foreman K, et al,. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2095-2128.
2. Wedemeyer H, Duberg AS, Buti M, et al,. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21 (Suppl 1): 60-89.
3. Deuffic-Burban S, Deltenre P, Buti M, et al,. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology 2012; 143 (4): 974-985.
4. Razavi H, Waked I, Sarrazin C, et al,. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014 May; 21 (Suppl. 1): 34-59.
5. Gane E, Kershenobich D, Seguin-Devaux C, et al,. Strategies to manage hepatitis C virus (HCV) infection disease burden-volume 2. J Viral Hepat 2015; 22 (Suppl. 1): 46-73.
6. Hatzakis A, Chulanov V, Gadano AC, et al,. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm-volume 2. J Viral Hepat 2015; 22 (Suppl. 1): 26-45.
7. Sievert W, Altraif I, Razavi HA, et al,. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011; 31 (Suppl 2): 61-80.
8. Kershenobich D, Razavi HA, Sanchez-Avila JF, et al,. Trends and projections of hepatitis C virus epidemiology in Latin America. Liver Int 2011; 31 (Suppl. 2): 18-29.
9. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST,. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57 (4): 1333-1342.
10. Lavanchy D,. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17 (2): 107-115.
11. Cornberg M, Razavi HA, Alberti A, et al,. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011; 31 (Suppl. 2): 30-60.
12. Hope VD, Eramova I, Capurro D, Donoghoe MC,. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 2014; 142 (2): 270-286.
13. Sibley A, Han KH, Abourached A, et al,. The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm-volume 3. J Viral Hepat 2015; 22 (Suppl 4): 21-41.
14. United Nations. Department of Economic and Social Affairs.Population Division. World population prospects: The 2012 revision. Population database. 2014. New York, United Nations. 6-18-2014.
15. IMS Health. IMS Health MIDAS Data. IMS Health. 1-1-2013.
16. Estonian Health Board. Registered new cases of select communicable diseases and incidence rate per 100 000 inhabitants by gender and age group. Estonian Health Board; 2014 May 12. Report No.: NH02.
17. Tallo T, Norder H, Tefanova V, et al,. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol 2007; 79 (4): 374-382.
18. Estonian Health Insurance Fund. Drug Statistics IFN+RBV and PEG+RBV: Number of treated patients with a CHC diagnosis-2002-2014. 2015. 3-25-2015.
19. Sarvari C, Ujhelyi E, Szlávik J, et al,. Determination of hepatitis C virus genotypes in Hungary using the Trugene HCV 5'NC genotyping test. 2010 Jun 3; Graz: De Gruyter; 2010 p. A21.
20. IRODaT. International Registry on Organ Donation and Transplantation. 7-26-2015. Barcelona, Spain, IRODaT. 3-1-2015.
21. Ministry of Health Republic of Indonesia. Report on the National Basic Health Research (RISKESDAS) 2007. Jakarta: The National Institute of Health Research and Development (NIHRD), Ministry of Health, Republic of Indonesia; 2010.
22. Inoue Y, Sulaiman HA, Matsubayashi K, et al,. Genotypic analysis of hepatitis C virus in blood donors in Indonesia. Am J Trop Med Hyg 2000; 62 (1): 92-98.
23. Merat S, Rezvan H, Nouraie M, et al,. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis 2010; 14 (Suppl. 3): e113-e116.
24. Poustchi H, Esmaili S, Mohamadkhani A, et al,. The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study. PLoS ONE 2011; 6 (8): e23830.
25. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S,. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res 2007; 37 (2): 101-103.
26. Geramizadeh B, Nikeghbalian S, Kazemi K, et al,. Hepatocellular carcinoma in explanted livers of patients with genotype d HBV cirrhosis: report of the first experience from Iran. Arch Iran Med 2013; 16 (6): 348-350.
27. Tanaka J, Koyama T, Mizui M, et al,. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirology 2011; 54 (4): 185-195.
28. Tanaka J, Kumagai J, Katayama K, et al,. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3 485 648 first-time blood donors during 1995-2000. Intervirology 2004; 47 (1): 32-40.
29. The Japanese Liver Transplantation Society. Liver Transplantation in Japan-Registry by the Japanese Liver Transplantation Society. Transplant 2011; 47 (6): 416-428.
30. Tolmane I, Rozentale B, Keiss J, Arsa F, Brigis G, Zvaigzne A,. The prevalence of viral hepatitis C in Latvia: a population-based study. Medicina (Kaunas) 2011; 47 (10): 532-535.
31. Centre for Disease Prevention and Control of Latvia. Reports on infectious and parasitic diseases in 2010-2014. Riga, Latvia: Centre for Disease Prevention and Control of Latvia; 2015.
32. Biedriba "Apvieniba HIV LV". The situation with hepatitis C (HCV) and its treatment in Latvia. 2011. 1-5-2015.
33. Centre for Disease Prevention and Control of Latvia. Infectious diseases statistics 2002-2014. 2015. 1-5-2015.
34. National Health Service Latvia. Statistics. 2015. Riga. 4-21-2015.
35. Abourached A, Selim AK, Walid A,. Epidemiology of hepatitis B and C in Lebanon. J Med Liban 2015; Forthcoming.
36. Araj GF, Kfoury-Baz EE, Barada KA, Nassif RE, Alami SY,. Hepatitis C virus: prevalence in Lebanese blood donors and brief overview of the disease. J Med Liban 1995; 43 (1): 11-16.
37. Baddoura R, Haddad C, Germanos M,. Hepatitis B and C seroprevalence in the Lebanese population. East Mediterr Health J 2002; 8 (1): 150-156.
38. Sharara AI, Ramia S, Ramlawi F, Fares JE, Klayme S, Naman R,. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect 2007; 135 (3): 427-432.
39. Sharara A, Khalife M, Yaghi C, Yaghi C, Sayegh R, Khoury G,. Update on the Status of Liver Transplantation in Lebanon. J Med Liban 2001; 49 (2): 117-120.
40. Faraj WG, Fakih H, Khalife M,. Liver transplantation in Lebanon: a single center experience. Liver Transplant 2010; 16: S195.
41. Liakina V, Valantinas J,. Anti-HCV prevalence in the general population of Lithuania. Med Sci Monit 2012; 18 (3): H28-H35.
42. Speiciene D, Kotoviene L, Mickevicius A, Liakina V, Valantinas J,. Efficacy of treatment with Pegylated Interferon and Ribavirin in patients with chronic HCV infection "under real life" conditions. Medicinos teorija ir praktika 2014; 21 (1): 23-32.
43. Liakina V, Speiciene D, Irnius A, Valantinas J,. Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C. Med Sci Monit 2009; 15 (4): H17-H23.
44. IRODaT. International Registry on Organ Donation and Transplantation. 7-9-2014. Barcelona, Spain, IRODaT. 3-1-2014.
45. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H,. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61 (Suppl. 1): S45-S57.
46. Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU,. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 2010; 16 (Suppl): S15-S23.
47. Khan NU, Ali I, Ahmad NU, et al,. Prevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV. Virol J 2011; 8: 154.
48. Attaullah S, Khan S, Ali I,. Hepatitis C virus genotypes in Pakistan: a systemic review. Virol J 2011; 8: 433.
49. Roghay S,. 500th Pakistani to get liver transplant in India returns home. The News 2014 Apr 25.
50. Shifa International Hospitals Ltd. Liver Transplant. 2013.
51. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L,. The prevalence and risk factors of hepatitis C virus infection in adult population in Romania: a nationwide survey 2006-2008. J Gastrointestin Liver Dis 2010; 19 (4): 373-379.
52. Sultana C, Oprisan G, Szmal C, et al,. Molecular epidemiology of hepatitis C virus strains from Romania. J Gastrointestin Liver Dis 2011; 20 (3): 261-266.
53. Ministry of Health Romania. Romania National Transplant Agency. 2015.
54. Popescu I, Ionescu M, Brasoveanu V, Hrehoret D, Matei E, Dorobantu B,. Liver transplantation in Romania-Retrospective analysis of 300 cases. AFH 2011; 16: 59-67.
55. World Health Organization. The growing threats of hepatitis B and C in the Eastern Mediterranean Region: A call for action. World Health Organization Regional Committee for the Eastern Mediterranean, editor. 2009.
56. Mohammed AS,. Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia. Malays J Med Sci 2013 Mar; 20 (2): 41-46.
57. Al-Faleh FZ, Ramia S, Arif M, et al,. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: a community-based study. Ann Trop Med Parasitol 1995; 89 (4): 431-437.
58. Abozaid SM, Shoukri M, Al-Qahtani A, Al-Ahdal MN,. Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidence. Ann Saudi Med 2013; 33 (1): 1-5.
59. Saudi Center for Organ Transplantation. 2012 Annual Report. 2012. 2012.
60. Seme K, Vrhovac M, Mocilnik T, et al,. Hepatitis C virus genotypes in 1 504 patients in Slovenia, 1993 to 2007. J Med Virol 2009; 81 (4): 634-639.
61. Kopilovic B, Poljak M, Seme K, Klavs I,. Hepatitis C virus infection among pregnant women in Slovenia: study on 31 849 samples obtained in four screening rounds during 1999, 2003, 2009 and 2013. Euro Surveill 2015; 20 (22).
62. Matičič M, Kastelic A,. National clinical guidelines for the management of HCV infection in drug users in Slovenia. Zdrav Vestn 2009; 78: 529-539.
63. Brinovec V, Lesnicar G, Maticic M, et al,. Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia. Hepatogastroenterology 2002; 49 (47): 1320-1325.
64. Brinovec V, Lesnicar G, Meglic-Volkar J, et al,. Treatment of chronic hepatitis C: our experience. Hepatogastroenterology 2004; 51 (56): 494-499.
65. The Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of hepatitis C. Clin Mol Hepatol 2014; 20 (2): 89-136.
66. Kim d, Kim IH, Jeong SH, et al,. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int 2013; 33 (4): 586-594.
67. Seong MH, Kil H, Kim YS, et al,. Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol 2013; 85 (10): 1724-1733.
68. Korean Network for Organ Sharing. 2013 Statistical Yearbook of Organ Transplant. Seoul, Korea; 2013. Report No.: 11-1351155-000001-10.
69. Lee SG,. Current status of liver transplantation in Korea. Korean J Gastroenterol 2005; 46 (2): 75-83.
70. Al SL, Abdul RM, John TJ, Al HA,. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Transfusion 2012; 52 (11): 2300-2309.
71. Abdullah S,. Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia. Malays J Med Sci 2013; 20 (2): 41-46.
72. Abro AH, Al-Dabal L, Younis NJ,. Distribution of hepatitis C virus genotypes in Dubai, United Arab Emirates. J Pak Med Assoc 2010; 60 (12): 987-990.
73. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H,. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61 (1S): S45-S57.